Dergiler / Journal of Clinical Research in Pediatric Endocrinology / 2021 / Cilt: 13 - Sayı: 2

Three Patient Kindred with a Novel Phenotype of Osteogenesis Imperfecta due to a COL1A1 Variant

Sayfa
218–224
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We describe three family members with a unique presenting phenotypeof OI, characterized by cessation of nontraumatic fractures after the first two years of life.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Osteogenesis imperfecta (OI) is characterized by fractures and progressive bone deformities.
📊
Temel Bulgular & Veri:Fracture rates peak during the toddler andadolescent years and decline during adulthood but do not stop entirely.
💡
Sonuç & Katkı:We describe three family members with a unique presenting phenotypeof OI, characterized by cessation of nontraumatic fractures after the first two years of life.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Osteogenesis imperfecta (OI) is characterized by fractures and progressive bone deformities. Fracture rates peak during the toddler andadolescent years and decline during adulthood but do not stop entirely. We describe a kindred, the affected members of which were themother and two sons, who presented with an apparently unique phenotype of OI. Our patients demonstrated a pattern of prenatal bonedeformities followed by multiple, nontraumatic long bone fractures within the first two years of life and then an absence of nontraumaticfractures thereafter. No extra-skeletal manifestations have been noted to date. The mother did not receive bisphosphonate therapy buthad no nontraumatic fractures after the age of five months. Intravenous bisphosphonate therapy was started for both sons within twomonths of birth, with the most recent infusions at age 18 months and 28 months in Patients 2 and 3, respectively. Two patients harboreda variant of uncertain significance in the COL1A1 gene. This heterozygous variant, c.3548C>T; p.(Pro1183Leu), is listed in the OI VariantDatabase as affecting only one other individual with osteopenia. We describe three family members with a unique presenting phenotypeof OI, characterized by cessation of nontraumatic fractures after the first two years of life.

🔖

Bu Makaleye Atıf Yap

GUPTA, N., GREGORY, S. W., DEYLE, D. R., TEBBEN, P. J. (2021). Three Patient Kindred with a Novel Phenotype of Osteogenesis Imperfecta due to a COL1A1 Variant. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 13 - Sayı: 2, 218–224. https://ajindex.com/articles/347734

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Pollitt RC, Saraff V, Dalton A, Webb EA, Shaw NJ, Sobey GJ, Mughal MZ, Hobson E, Ali F, Bishop NJ, Arundel P, Högler W, Balasubramanian M. Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations. Am J Med Genet A 2016
  2. Epub 2016 Aug 30 2. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007
  3. Marini JC, Blissett AR. New genes in bone development: what’s new in osteogenesis imperfecta. J Clin Endocrinol Metab 2013
  4. Epub 2013 Jun 1 4. Pace JM, Atkinson M, Willing MC, Wallis G, Byers PH. Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta. Hum Mutat 2001
  5. Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, Dalton A. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat 2006
  6. OI Database. Osteogenesis Imperfecta Variant Database COL1A1. Leiden University, Medical Center, 2018. 7. Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014
  7. Epub 2014 Apr 8 8. Folkestad L, Hald JD, Ersbøll AK, Gram J, Hermann AP, Langdahl B, Abrahamsen B, Brixen K. Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register-Based Cohort Study. J Bone Miner Res 2017
  8. Epub 2016 Aug 29 9. Clinical Growth Charts. Centers for Disease Control and Prevention. Last accessed date: April 2021. Available from: https://www.cdc.gov/ growthcharts/clinical_charts.htm 10. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child 2002
  9. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smi